{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:10:34Z","timestamp":1784279434609,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.aprim.2026.103473","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T10:54:46Z","timestamp":1771844086000},"page":"103473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adecuaci\u00f3n farmacoterap\u00e9utica en mujeres con osteoporosis posmenop\u00e1usica atendidas en una consulta de Atenci\u00f3n Primaria"],"prefix":"10.1016","volume":"58","author":[{"given":"Ricardo","family":"Cruz Serrano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda del Mar","family":"Ala\u00f1\u00f3n Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Mercedes","family":"S\u00e1nchez-Cruzado del Olmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aprim.2026.103473_bib0130","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Consensus Development Panel of Osteoporosis Prevention, Diagnosis and Therapy","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.aprim.2026.103473_bib0135","first-page":"S8","article-title":"Impacto socioecon\u00f3mico de la osteoporosis","volume":"2","author":"Nogu\u00e9s Sol\u00e1n","year":"2010","journal-title":"Rev Osteoporos Metab Miner"},{"key":"10.1016\/j.aprim.2026.103473_bib0140","first-page":"117","article-title":"Actualizaci\u00f3n en el abordaje y tratamiento de la osteoporosis","volume":"25","author":"Orozco","year":"2001","journal-title":"Inf Ter Sist Nac Salud"},{"key":"10.1016\/j.aprim.2026.103473_bib0145","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.reuma.2018.09.004","article-title":"Recomendaciones de la Sociedad Espa\u00f1ola de Reumatolog\u00eda sobre osteoporosis","volume":"15","author":"Naranjo Hern\u00e1ndez","year":"2019","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.aprim.2026.103473_bib0150","series-title":"Documentos Cl\u00ednicos SEMERGEN. \u00c1rea Aparato Locomotor. Segunda edici\u00f3n","year":"2009"},{"key":"10.1016\/j.aprim.2026.103473_bib0155","series-title":"Osteoporosis. Recomendaciones para el uso racional del medicamento en el tratamiento farmacol\u00f3gico de las enfermedades reum\u00e1ticas y musculoesquel\u00e9ticas","year":"2022"},{"key":"10.1016\/j.aprim.2026.103473_bib0160","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/M22-1034","article-title":"Clinical Guidelines Committee of the American College of Physicians. Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults: a living clinical guideline from the American College of Physicians","volume":"176","author":"Qaseem","year":"2023","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.aprim.2026.103473_bib0165","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11657-025-01588-3","volume":"20","author":"Gregson","year":"2025","journal-title":"Arch Osteoporos."},{"key":"10.1016\/j.aprim.2026.103473_bib0170","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/GME.0000000000001831","article-title":"Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society","volume":"28","year":"2021","journal-title":"Menopause"},{"key":"10.1016\/j.aprim.2026.103473_bib0175","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1503\/cmaj.1030757","article-title":"The Canadian Task Force on Preventive Health Care. Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: recommendation statement from the Canadian TaskForce on Preventive Health Care","volume":"170","author":"Cheung","year":"2004","journal-title":"CMAJ."},{"key":"10.1016\/j.aprim.2026.103473_bib0180","series-title":"Adecuaci\u00f3n farmacoterap\u00e9utica. Recomendaciones. Abordaje terap\u00e9utico de la osteoporosis postmenop\u00e1usica","year":"2019"},{"key":"10.1016\/j.aprim.2026.103473_bib0185","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.semerg.2009.12.004","article-title":"Adecuaci\u00f3n del tratamiento preventivo de fracturas osteopor\u00f3ticas en mujeres posmenop\u00e1usicas","volume":"36","author":"Amaya","year":"2010","journal-title":"Semergen"},{"key":"10.1016\/j.aprim.2026.103473_bib0190","first-page":"40","article-title":"An\u00e1lisis de la prescripci\u00f3n de antirresortivos en el tratamiento de la osteoporosis en Atenci\u00f3n Primaria","volume":"24","author":"Terol","year":"2007","journal-title":"Rev Valenc Med Fam"},{"key":"10.1016\/j.aprim.2026.103473_bib0195","first-page":"77","article-title":"Uso adecuado en Atenci\u00f3n Primaria de los f\u00e1rmacos antirresortivos frente a la osteoporosis","volume":"3","author":"Mart\u00ednez Laguna","year":"2011","journal-title":"Rev Osteoporos Metab Miner"},{"key":"10.1016\/j.aprim.2026.103473_bib0200","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1157\/13128567","article-title":"An\u00e1lisis comparativo frente a la evidencia del manejo de la osteoporosis en una comarca de atenci\u00f3n primaria","volume":"40","author":"Arana-Arria","year":"2008","journal-title":"Aten Primaria"},{"key":"10.1016\/j.aprim.2026.103473_bib0205","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.aprim.2009.10.022","article-title":"Caracter\u00edsticas cl\u00ednicas de los pacientes con tratamiento para la osteoporosis en un centro de Atenci\u00f3n Primaria: \u00bfa qui\u00e9n tratamos en nuestras consultas?","volume":"42","author":"De Felipe","year":"2010","journal-title":"Aten Primaria"},{"key":"10.1016\/j.aprim.2026.103473_bib0210","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0212-6567(04)79391-9","article-title":"Abordaje de la osteoporosis en un centro de Atenci\u00f3n Primaria","volume":"33","author":"Zwart Salmer\u00f3n","year":"2004","journal-title":"Aten Primaria"},{"key":"10.1016\/j.aprim.2026.103473_bib0215","first-page":"59","article-title":"Adecuaci\u00f3n del manejo cl\u00ednico de la osteoporosis a las gu\u00edas de la SEIOMM. Estudio OPINHO-PC","volume":"17","author":"Diez P\u00e9rez","year":"2008","journal-title":"Rev Esp Enferm Metab Oseas"},{"key":"10.1016\/j.aprim.2026.103473_bib0220","article-title":"Osteoporosis treatment: current drugs and future developments","volume":"15","author":"Chen","year":"2024","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.aprim.2026.103473_bib0100","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00198-020-05557-z","article-title":"The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study","volume":"32","author":"McCloskey","year":"2021","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.aprim.2026.103473_bib0225","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11657-021-01048-8","article-title":"Prevalence of FRAX risk factors and the osteoporosis treatment gap among women\u00a0\u2265\u00a070 years of age in routine primary care across 8 countries in Europe","volume":"17","author":"McCloskey","year":"2022","journal-title":"Arch Osteoporos."},{"key":"10.1016\/j.aprim.2026.103473_bib0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2022.101754","article-title":"Osteoporosis in 2022: care gaps to screening and personalised medicine","volume":"36","author":"Curtis","year":"2022","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"10.1016\/j.aprim.2026.103473_bib0235","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","article-title":"FRAX\u00ae and the assessment of fracture probability in men and women from the UK","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.aprim.2026.103473_bib0240","series-title":"Recomendaciones para la valoraci\u00f3n y tratamiento de la osteoporosis primaria en mujeres de la Comunidad de Madrid","year":"2015"},{"key":"10.1016\/j.aprim.2026.103473_bib0245","first-page":"112","article-title":"Osteoporosis secundaria a f\u00e1rmacos","volume":"10","author":"Sall\u00e9s","year":"2009","journal-title":"Semin Fund Esp Reumatol"}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656726000314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656726000314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T14:01:37Z","timestamp":1775311297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212656726000314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0212656726000314"],"URL":"https:\/\/doi.org\/10.1016\/j.aprim.2026.103473","relation":{},"ISSN":["0212-6567"],"issn-type":[{"value":"0212-6567","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adecuaci\u00f3n farmacoterap\u00e9utica en mujeres con osteoporosis posmenop\u00e1usica atendidas en una consulta de Atenci\u00f3n Primaria","name":"articletitle","label":"Article Title"},{"value":"Atenci\u00f3n Primaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aprim.2026.103473","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"103473"}}